Study of the Enterprise Self-Expanding Stent System With Endovascular Coil Embolization of Wide- Neck Saccular Intracranial Artery Aneurysms
Phase 1
Completed
- Conditions
- Intracranial, Wide-Neck, Saccular Aneurysms
- Registration Number
- NCT00233753
- Lead Sponsor
- Codman & Shurtleff
- Brief Summary
Cordis Self Expanding Stent for use with embolic coils for the treatment of wide-neck, intracranial, saccular aneurysms arising from a parent vessel
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- pts with intracranial, wide-neck, saccular aneurysms
Exclusion Criteria
- Subject with Hunt and Hess Grade IV or V subarachnoid hemorrhage.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the effectiveness of self-expanding stents in treating wide-neck saccular intracranial aneurysms?
How does the Enterprise stent compare to balloon-assisted coiling in managing wide-neck aneurysms?
What biomarkers are associated with successful endovascular coil embolization outcomes in intracranial aneurysms?
What are the potential adverse events of using Enterprise stents for aneurysm treatment and how are they managed?
Are there combination therapies involving self-expanding stents and flow diverters for wide-neck saccular aneurysms?